Accurate, Focused Research on Law, Technology and Knowledge Discovery Since 2002

You Are Here: Home » Archives: January 2011

Daily Archives: January 19, 2011

Present Law And Background Information On Federal Excise Taxes

by on

JCS-1-11 (January 19, 2011) – Present Law And Background Information On Federal Excise Taxes

  • “The Internal Revenue Code (the “Code”) imposes numerous excise taxes on goods and services.1 In addition to excise taxes the primary purpose of which is revenue production, excise taxes also are imposed to promote adherence to other policies (e.g., penalty excise taxes). Many trust funds established by the Federal Government are financed with dedicated excise tax receipts. This document 2 provides a description of present-law Federal excise taxes, and when applicable, background information on trust funds financed with excise tax revenues.”

    • Supreme Court Affirms Right to Informational Privacy, But Says Privacy Act Safeguards Sufficient for NASA Records

    by on

    EPIC: “The Supreme Court has issued a decision in NASA v. Nelson, a case brought by NASA scientists who argued that the government’s invasive background checks violated the Constitution. The Supreme Court found amicus brief , cosigned by 27 technical experts and legal scholars, which highlighted problems with the Privacy Act, including the “routine use”… Continue Reading

    Present Law And Historical Overview Of The Federal Tax System

    by on

    Present Law And Historical Overview Of The Federal Tax System, Scheduled for a Public Hearing Before the Committee on Ways and Means on January 20, 2011, Prepared by the Staff of the Joint Committee on Taxation, January 18, 2011, JCX-1-11 (January 18, 2011) This document, prepared by the staff of the Joint Committee on Taxation,… Continue Reading

    FDA to improve most common review path for medical devices

    by on

    News release: “The U.S. Food and Drug Administration today unveiled a plan containing 25 actions it intends to implement during 2011 to improve the most common path to market for medical devices. Key actions include: Streamlining the “de novo” review process for certain innovative, lower-risk medical devices, Clarifying when clinical data should be submitted in… Continue Reading